Η ελληνική συμμετοχή στα προγράμματα Health και Innovative Medicines Initiative στο 7ο Πρόγραμμα Πλαίσιο για την Έρευνα της ΕΕ την περίοδο 2007-2013 - page 5

1
Table of Content
1. ... The Programme HEALTH in FP7 ..............................................................5
1.1. .... Goal and Structure ...................................................................................... 5
1.2. .... The HEALTH Calls ...................................................................................... 6
1.3. .... HEALTH in “Horizon 2020” .......................................................................... 8
2. ... Statistical Data for HEALTH ......................................................................9
2.1. .... The Participation from Greece & Europe..................................................... 9
2.1.1.. FP7-HEALTH Calls ..................................................................................... 9
2.1.2.. Innovative Medicines Initiative (IMI) calls ...................................................11
2.2. .... Competition in HEALTH ............................................................................ 12
2.2.1.. FP7-HEALTH calls .................................................................................... 12
2.2.2.. Innovative Medicines Initiatives (IMI) calls................................................. 13
2.3. .... Distribution of Funding .............................................................................. 14
3. ... The Greek Participation...........................................................................17
3.1. .... The Evolution of the Greek Participation ................................................... 17
3.1.1.. FP7-HEALTH calls .................................................................................... 17
3.1.2.. Innovative Medicines Initiative (IMI) calls .................................................. 18
3.2. .... The Greek Projects ................................................................................... 22
3.2.1.. FP7-HEALTH calls .................................................................................... 22
3.2.2.. Innovative Medicines Initiative(IMI) calls ................................................... 38
3.3. .... Profile of the Greek Participants................................................................ 39
3.3.1.. FP7-HEALTH calls .................................................................................... 39
3.3.2.. Innovative Medicines Initiative (IMI) calls .................................................. 42
3.4. .... Thematic fields of the Greek Projects........................................................ 45
3.4.1.. FP7-HEALTH calls .................................................................................... 45
3.5. .... Greek women participants in the HEALTH Programme ........................... 50
4. ... Scientific Networks and Partnerships ......................................................51
4.1 ..... The networking of Greek Organisations .................................................... 51
4.2 ..... Collaborating Countries............................................................................. 51
4.3 ..... Collaborations with companies.................................................................. 53
5. ... The involvement of Greek regions...........................................................54
5.1. .... Proposals and projects by region .............................................................. 54
5.1.1.. FP7-HEALTH calls .................................................................................... 54
5.1.2.. Innovative Medicines Initiative (IMI) calls .................................................. 56
5.2. .... Participants and thematic fields by Region ................................................ 56
6. ... The Greek Evaluators as Proof of Excellence .........................................59
7. ... The Impact of the Programme.................................................................61